SGLT2 Inhibitor Safe for Kidneys in Hospitalized COVID Patients | MedPage Today
Forxiga – Indicated for Treatment of Symptomatic Heart Failure
FARXIGA Significantly Reduced the Risk of Cardiovascular Death or Worsening of Heart Failure in Patients with Mildly Reduced or Preserved Ejection Fraction in DELIVER Phase III Trial | DAIC